Does CAPIVASERTIB Cause Hyperglycaemia? 152 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Hyperglycaemia have been filed in association with CAPIVASERTIB (TRUQAP). This represents 9.0% of all adverse event reports for CAPIVASERTIB.
152
Reports of Hyperglycaemia with CAPIVASERTIB
9.0%
of all CAPIVASERTIB reports
16
Deaths
71
Hospitalizations
How Dangerous Is Hyperglycaemia From CAPIVASERTIB?
Of the 152 reports, 16 (10.5%) resulted in death, 71 (46.7%) required hospitalization, and 29 (19.1%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPIVASERTIB. However, 152 reports have been filed with the FAERS database.
What Other Side Effects Does CAPIVASERTIB Cause?
Diarrhoea (278)
Rash (253)
Death (228)
Nausea (96)
Vomiting (81)
Blood glucose increased (70)
Fatigue (67)
Malignant neoplasm progression (62)
Disease progression (61)
Pyrexia (55)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which CAPIVASERTIB Alternatives Have Lower Hyperglycaemia Risk?
CAPIVASERTIB vs CAPLACIZUMAB
CAPIVASERTIB vs CAPLACIZUMAB-YHDP
CAPIVASERTIB vs CAPMATINIB
CAPIVASERTIB vs CAPREOMYCIN
CAPIVASERTIB vs CAPSAICIN